• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽可能长时间地治疗血液学患者。

[Treat haematology patients as long as possible].

作者信息

Huijgens Peter C

机构信息

VU Medisch Centrum, afd. Hematologie, Amsterdam, the Netherlands.

出版信息

Ned Tijdschr Geneeskd. 2010;154(51-52):A2882.

PMID:21211076
Abstract

One of the universal human rights is the right to live. This right should not be restricted for patients with a haematological malignancy. All treatment options should be made available to these patients for as long as treatment is reasonable and beneficial. Healthcare should not be considered as expenditure, but rather as investment giving profits in return, not least in the form of employment opportunities.

摘要

普遍人权之一是生存权。这项权利不应限制于血液系统恶性肿瘤患者。只要治疗合理且有益,就应为这些患者提供所有治疗选择。医疗保健不应被视为支出,而应被视为一种能带来回报的投资,尤其是以就业机会的形式。

相似文献

1
[Treat haematology patients as long as possible].尽可能长时间地治疗血液学患者。
Ned Tijdschr Geneeskd. 2010;154(51-52):A2882.
2
Intensive care for patients with medical complications of haematological malignancy: is it worth it?血液系统恶性肿瘤合并症患者的重症监护:是否值得?
Schweiz Med Wochenschr. 1998 Sep 26;128(39):1467-73.
3
Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.顺铂和紫杉醇腹腔内注射与卡铂和紫杉醇静脉注射治疗Ⅲ期卵巢癌的疗效对比:成本效益分析
Gynecol Oncol. 2007 Sep;106(3):476-81. doi: 10.1016/j.ygyno.2007.05.043. Epub 2007 Aug 3.
4
Cost effectiveness, chemotherapy, and the clinician.成本效益、化疗与临床医生。
Breast Cancer Res Treat. 2009 Apr;114(3):597-8. doi: 10.1007/s10549-008-0142-y. Epub 2008 Aug 10.
5
[Cost of cancer in France: pharmaceutical expenditure as part of global patients' care].[法国癌症治疗成本:药品支出在患者整体治疗费用中的占比]
Bull Cancer. 2008 May;95(5):535-41. doi: 10.1684/bdc.2008.0644.
6
Costs of chemotherapy in the treatment of colorectal cancer.结直肠癌治疗中化疗的费用。
Eur J Health Econ. 2006 Jun;7(2):145-6. doi: 10.1007/s10198-006-0356-z.
7
Economic and cost-effectiveness issues in breast cancer treatment.乳腺癌治疗中的经济与成本效益问题。
Semin Oncol. 1996 Feb;23(1 Suppl 2):98-104.
8
[Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].[干细胞移植及特定化疗病例成本的自下而上分析]
Klin Padiatr. 2003 May-Jun;215(3):179-84. doi: 10.1055/s-2003-39379.
9
Health care costs for treatment of disseminated breast cancer.转移性乳腺癌的治疗医疗费用。
Eur J Cancer. 2009 Jul;45(11):1987-91. doi: 10.1016/j.ejca.2009.03.023. Epub 2009 Apr 22.
10
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.输注化疗与大剂量化疗给药成本比较:三种常见肿瘤中五种标准化疗方案的分析——第一部分。基于收费的成本模型预测
Cancer. 1996 Jul 15;78(2):294-9. doi: 10.1002/(SICI)1097-0142(19960715)78:2<294::AID-CNCR16>3.0.CO;2-R.